NKore is using a proprietary approach to “Supercharging” allogeneic Natural Killer Cells to deploy a new era in immuno-therapeutic medicine for the treatment of cancer in patients of all ages. At NKore, we put patients first!
NKore BioTherapeutics is a cellular-based biotherapeutics company focused on the early detection, prevention, and treatment of cancer. Our technology is based on a proprietary method of activating natural killer (NK) cells, creating Supercharged Natural Killer (sNK) cells used as a novel oncology immunotherapy platform. Our proprietary activation method enhances NK cells’ overall effectiveness, making them significantly more potent (i.e., they are more cytotoxic to the cancer cells), while reducing the likelihood of tumor regeneration and metastasis.
The technology was developed by Dr. Anahid Jewett, the Company’s co-founder and Chief Scientific Advisor. Based on positive preclinical results, we believe that Dr. Jewett’s 30-plus years of researching NK cell function has resulted in the development of a novel and effective cancer immunotherapy. NKore’s current focus is to translate and replicate the positive preclinical results into human clinical trials and achieve marketing approval.
Dr. Jewett is one of the foremost global experts on Natural Killer Cell research. She has spent 30+ years studying Natural Killer cells and is currently the Director of the Tumor and Immunology lab at the global top ten medical research university, UCLA. Dr. Jewett believes in a combo therapy approach when treating cancer. She continues to lead a global effort to develop NK Cell therapeutics, and has developed cutting edge diagnostics.
At just 8 1/2 months old, Sophie Isabella Ryan was diagnosed with a very rare, low-grade Optic Pathway Glioma brain tumor. After learning that only 4 new drugs had been brought to market in 40 years for children with cancer her mother Tracy Ryan, one of NKore's 4 founders, dedicated her life to try and find a cure for Sophie. Through her dedication to this cause, the drive to launch NKore was born. Sophie's live tumor tissue, CSF brain fluid and blood have been studied extensively by Dr. Jewett, which have now led her team to groundbreaking discoveries that could help cancer patients just like Sophie.
Thank you for contacting our team at NKore!
We will get back to you as soon as possible.
All Rights Reserved | NKore Biotherapeutics, LLC | Privacy Policy | Terms of Service